ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent diseaseNicoletta Colombo, Siel Olbrecht, François Planchamp et al.|Annals of Oncology|2019Cited by 1.2k
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent diseaseJonathan A. Ledermann, Anna Fagotti, Xavier Matías‐Guiu et al.|Annals of Oncology|2024Cited by 277
European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer SurgeryDenis Querleu, Andreas du Bois, François Planchamp et al.|International Journal of Gynecological Cancer|2016Cited by 141
Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinomaLilach Kleinberg, Ben Davidson|Cancer|2006Cited by 71
Survivin, a Member of the Inhibitors of Apoptosis Family, Is Down-Regulated in Breast Carcinoma EffusionsLilach Kleinberg, Ben Davidson|American Journal of Clinical Pathology|2007Cited by 22